LIXTE BIOTECHNOLOGY HLDGS IN (LIXTW)
Institutional ownership reported to the SEC as of Q3 2025, across 20 quarters.
3
Reporting holders
$3.6K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Clear Street Group Inc. | $3.1K | 21,618 | 0.00% | new | FIRST |
| Newbridge Financial Services Group, Inc. | $361 | 2,500 | 0.00% | 2q | HELD |
| UBS Group AG | $125 | 867 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 3 | $3.6K | 24,985 | 1 | 0 | 0 | 0.0% |
| Q2 2025 | 4 | $1.4K | 50,485 | 1 | 0 | 1 | 0.0% |
| Q1 2025 | 3 | $1.6K | 48,786 | 1 | 0 | 1 | 0.0% |
| Q4 2024 | 2 | $1.4K | 49,886 | 0 | 0 | 1 | 0.0% |
| Q3 2024 | 3 | $4.0K | 86,601 | 0 | 0 | 3 | 0.0% |
| Q2 2024 | 4 | $5.9K | 97,238 | 1 | 1 | 1 | 0.0% |
| Q1 2024 | 4 | $3.4K | 67,982 | 1 | 1 | 0 | 0.0% |
| Q4 2023 | 3 | $2.4K | 64,339 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 2 | $4.3K | 64,129 | 0 | 0 | 1 | 0.0% |
| Q2 2023 | 3 | $9.4K | 118,440 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 4 | $7.3K | 88,313 | 3 | 0 | 1 | 0.0% |
| Q4 2022 | 2 | $607 | 98,117 | 0 | 0 | 1 | 0.0% |
| Q3 2022 | 2 | $5.0K | 102,370 | 0 | 0 | 1 | 0.0% |
| Q2 2022 | 5 | $29.0K | 236,863 | 1 | 1 | 3 | 0.0% |
| Q1 2022 | 4 | $33.0K | 160,676 | 2 | 2 | 0 | 0.0% |
| Q4 2021 | 2 | $11.0K | 24,184 | 0 | 0 | 2 | 0.0% |
| Q3 2021 | 2 | $25.0K | 44,520 | 0 | 1 | 1 | 0.0% |
| Q2 2021 | 3 | $125.0K | 163,477 | 0 | 1 | 2 | 0.0% |
| Q1 2021 | 4 | $173.0K | 212,206 | 1 | 1 | 2 | 0.0% |
| Q4 2020 | 3 | $339.0K | 375,783 | 2 | 0 | 0 | 0.0% |